medroxyprogesterone acetate has been researched along with Vascular Diseases in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (80.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Asbury, EA; Collins, P; Elkington, AG; Gatehouse, PD; Hayward, CS; Kubba, A; Ong, PJ; Pennell, DJ; Sorensen, MB; Webb, CM; Yang, GZ | 1 |
| Kistner, RW | 1 |
| Luyando, H; Rustrian, A | 1 |
| Atkinson, EN; Dana, WJ; Edwards, CL; Freedman, RS; Gershenson, DM; Jolles, CJ; Jones, LA; Saul, PB | 1 |
1 trial(s) available for medroxyprogesterone acetate and Vascular Diseases
| Article | Year |
|---|---|
Long-term use of contraceptive depot medroxyprogesterone acetate in young women impairs arterial endothelial function assessed by cardiovascular magnetic resonance.
Topics: Adult; Amenorrhea; Brachial Artery; Delayed-Action Preparations; Endothelium, Vascular; Estradiol; Female; Humans; Magnetic Resonance Angiography; Male; Medroxyprogesterone Acetate; Middle Aged; Nitroglycerin; Reference Values; Reproducibility of Results; Time; Ultrasonography, Interventional; Vascular Diseases; Vasomotor System | 2002 |
4 other study(ies) available for medroxyprogesterone acetate and Vascular Diseases
| Article | Year |
|---|---|
Sixth fertility and sterility congress--a review.
Topics: Biology; Chlormadinone Acetate; Clomiphene; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Copper; Disease; Embolism; Endocrine System; Estrogens; Evaluation Studies as Topic; Family Planning Services; Hormones; Incidence; Infections; Injections; Intrauterine Devices; Medroxyprogesterone Acetate; Menstruation Disturbances; Norgestrel; Pelvic Inflammatory Disease; Physiology; Progesterone Congeners; Quinestrol; Research; Research Design; Therapeutics; Thromboembolism; Time; Uterine Perforation; Vascular Diseases; Zinc | 1968 |
Newer synthetic progestins for the treatment of endometriosis.
Topics: Blood Coagulation; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Digestive System; Disease; Embolism; Ethinyl Estradiol; Family Planning Services; Hemorrhage; Injections; Lynestrenol; Medroxyprogesterone Acetate; Menstrual Cycle; Menstruation; Mestranol; Metrorrhagia; Nausea; Norethindrone; Norethynodrel; Pseudopregnancy; Reproduction; Signs and Symptoms; Thromboembolism; Vascular Diseases | 1970 |
[Clinical investigation of medroxyprogesterone acetate and estradiol cypionate in contraceptive injection administered monthly].
Topics: Biology; Body Weight; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Disease; Endocrine System; Endometrium; Estradiol; Estrogens; Family Planning Services; Genitalia; Genitalia, Female; Hormones; Hypertension; Injections; Medroxyprogesterone Acetate; Physiology; Research; Urogenital System; Uterus; Vascular Diseases | 1975 |
Ethinyl estradiol and medroxyprogesterone acetate in patients with epithelial ovarian carcinoma: a phase II study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Ethinyl Estradiol; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Ovarian Neoplasms; Receptors, Estrogen; Receptors, Progesterone; Vascular Diseases | 1986 |